It has been shown that CaVβ1 regulates T cell function independent of VGCC channel activity.[47] Thus, lacidipine exerts immunomodulatory effects by inhibiting IDO in tumor cells, which activates effector T cells and inhibits regulatory T cells, rather than directly acting on T cells themselves. Here, IDO1 is linked to neoplasm.